Lv1
10 积分 2025-03-19 加入
Cyclic Peptide Screening Methods for Preclinical Drug Discovery
12天前
已完结
In Vitro ADME Profiling of PROTACs: Successes, Challenges, and Lessons Learned from Analysis of Clinical PROTACs from a Diverse Physicochemical Space
14天前
已完结
ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity–independent manner
14天前
已完结
Membrane‐Bounded Intracellular E3 Ubiquitin Ligase‐Targeting Chimeras (MembTACs) for Targeted Membrane Protein Degradation
17天前
已完结
Targeted degradation of extracellular secreted and membrane proteins
17天前
已完结
Recent progress in degradation of membrane proteins by PROTACs and alternative targeted protein degradation techniques
17天前
已完结
At The Interface: Small-Molecule Inhibitors of Soluble Cytokines
17天前
已完结
ByeTAC: Bypassing E-Ligase-Targeting Chimeras for Direct Proteasome Degradation
17天前
已完结
Discovery of a Novel Dihydroisoquinolinone Derivative as a Potent CDK9 Inhibitor Capable of Overcoming L156F Mutant for the Treatment of Hematologic Malignancies
1个月前
已完结
Discovery of novel flavonoid-based CDK9 degraders for prostate cancer treatment via a PROTAC strategy
1个月前
已完结
皖公网安备34019202002308
